Patient-Perceived Symptoms at the Center of Obstructive Sleep Apnea (OSA) Management: Validation of the French Version of the Patient-Reported Apnea Questionnaire (PRAQ)
Key facts
- Who runs it
- University Hospital, Bordeaux
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 100 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 30 Apr 2029
- Type of study
- Interventional
- Treatments tested
- Questionnaires
- Record updated
- 23 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age > 18 years
- Patients referred through a direct referral pathway (outpatient or admitted to the SUMS) with a high suspicion of OSA
- Patients whose native language is French and who can read and write French
- Patients capable of understanding and completing the questionnaires independently
- Patients able to make themselves available for the tests offered as part of their care and for follow-up visits
- Patients enrolled in or covered by a social security program
- Patients who have been informed and do not object to participating in the study
Who cannot take part
- Current psychiatric disorder (mood disorders, anxiety, psychosis, substance use disorder interfering with sleep) assessed during the interview with the investigator
- Current neurological disorder affecting sleep (neurodegenerative disease, stroke, epilepsy) assessed during the interview with the investigator
- Unstable cardiovascular or respiratory diseases
- Pregnant or breastfeeding women
- Patients under legal guardianship
- Refusal to participate expressed by the patient
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Obstructive sleep apnea (OSA) is a common and disabling sleep disorder in which the assessment and monitoring of symptoms are central to patient management. However, these steps require a shared understanding of the disease's clinical manifestations among patients, caregivers, and healthcare professionals in order to establish common therapeutic goals and meaningful clinical outcomes.
Read full original descriptionShow less
Improving symptoms as experienced and reported by patients has become a major public health priority at both the national and international levels. In France, this patient-centered approach has been identified as a strategic priority by the French National Authority for Health (Haute Autorité de Santé, HAS) in its 2019-2024 strategic plan. Its implementation has been supported through the development and use of Patient-Reported Outcome Measures (PROMs).
A disease-specific PROM for OSA, the Patient-Reported Apnea Questionnaire (PRAQ), has recently been developed and validated. The primary objective of this study is to validate a French version of the PRAQ. Secondary objectives are to evaluate the relationship between PRAQ scores and subjective sleep parameters, and to develop a shortened version of the questionnaire to facilitate its use in both clinical practice and research.
The group in the trial
- Experimental groupTreatment being tested
Patients who require a ventilatory polygraphy (VP) test as part of an initial evaluation for a high suspicion of OSA
Treatment: Questionnaires
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 23 September 2026